Chardan Capital Markets has recently initiated Mind Medicine (MindMed) Inc (MNMD) stock to Buy rating, as announced on December 20, 2024, according to Finviz. Earlier, on October 14, 2024, Leerink ...

Zura Bio Limited (NASDAQ:ZURA – Get Free Report) has been given an average rating of “Buy” by the seven ratings firms that ...

NATICK, Mass. - Allurion Technologies, Inc. (NYSE: ALUR), a company focused on obesity treatment solutions, has expanded its ...

Richard Giroux, the Chief Financial Officer and Chief Operating Officer of MeiraGTx Holdings plc (NASDAQ:MGTX), a biotechnology company with a market capitalization of $500 million, recently executed ...